Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Total 13F shares
-
12,943,792
-
Share change
-
+2,112,159
-
Total reported value
-
$84,133,481
-
Put/Call ratio
-
8.2%
-
Price per share
-
$6.50
-
Number of holders
-
59
-
Value change
-
+$14,995,061
-
Number of buys
-
36
-
Number of sells
-
22
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q1 2023
As of 31 Mar 2023,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,943,792 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, FMR LLC, VANGUARD GROUP INC, EAM Investors, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, BML Capital Management, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
59
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.